<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <originChamber>House</originChamber>
    <laws />
    <recordedVotes />
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Congressional tributes</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Health care costs and insurance</name>
          </item>
          <item>
            <name>Health care coverage and access</name>
          </item>
          <item>
            <name>Health care quality</name>
          </item>
          <item>
            <name>Health promotion and preventive care</name>
          </item>
          <item>
            <name>Medical research</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
          <item>
            <name>Research and development</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2019-03-18T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hres242ih/xml/BILLS-116hres242ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <introducedDate>2019-03-18</introducedDate>
    <titles>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <chamberName />
        <title>Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.</title>
        <chamberCode />
      </item>
      <item>
        <titleType>Display Title</titleType>
        <parentTitleType />
        <chamberName />
        <title>Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.</title>
        <chamberCode />
      </item>
    </titles>
    <committeeReports />
    <updateDate>2019-05-02T07:15:21Z</updateDate>
    <cosponsors>
      <item>
        <firstName>Gus</firstName>
        <middleName>M.</middleName>
        <state>FL</state>
        <lastName>Bilirakis</lastName>
        <bioguideId>B001257</bioguideId>
        <identifiers>
          <lisID>1838</lisID>
          <bioguideId>B001257</bioguideId>
          <gpoId>7881</gpoId>
        </identifiers>
        <fullName>Rep. Bilirakis, Gus M. [R-FL-12]</fullName>
        <sponsorshipWithdrawnDate />
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <party>R</party>
        <sponsorshipDate>2019-03-18</sponsorshipDate>
        <district>12</district>
      </item>
      <item>
        <firstName>Bill</firstName>
        <middleName />
        <state>TX</state>
        <lastName>Flores</lastName>
        <bioguideId>F000461</bioguideId>
        <identifiers>
          <gpoId>8173</gpoId>
          <bioguideId>F000461</bioguideId>
          <lisID>2065</lisID>
        </identifiers>
        <fullName>Rep. Flores, Bill [R-TX-17]</fullName>
        <sponsorshipWithdrawnDate />
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <party>R</party>
        <sponsorshipDate>2019-05-01</sponsorshipDate>
        <district>17</district>
      </item>
    </cosponsors>
    <createDate>2019-03-19T07:12:06Z</createDate>
    <cboCostEstimates />
    <congress>116</congress>
    <amendments />
    <relatedBills />
    <version>1.0.0</version>
    <committees>
      <billCommittees>
        <item>
          <type>Standing</type>
          <subcommittees />
          <name>Energy and Commerce Committee</name>
          <activities>
            <item>
              <date>2019-03-18T16:01:35Z</date>
              <name>Referred to</name>
            </item>
          </activities>
          <systemCode>hsif00</systemCode>
          <chamber>House</chamber>
        </item>
      </billCommittees>
    </committees>
    <notes />
    <summaries>
      <billSummaries />
    </summaries>
    <sponsors>
      <item>
        <fullName>Rep. Butterfield, G. K. [D-NC-1]</fullName>
        <identifiers>
          <lisID>1761</lisID>
          <gpoId>8024</gpoId>
          <bioguideId>B001251</bioguideId>
        </identifiers>
        <district>1</district>
        <party>D</party>
        <byRequestType />
        <middleName />
        <lastName>Butterfield</lastName>
        <firstName>G. K.</firstName>
        <state>NC</state>
        <bioguideId>B001251</bioguideId>
      </item>
    </sponsors>
    <calendarNumbers />
    <constitutionalAuthorityStatementText />
    <billType>HRES</billType>
    <billNumber>242</billNumber>
    <actions>
      <item>
        <actionDate>2019-03-18</actionDate>
        <links />
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <actionCode>H11100</actionCode>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2019-03-18</actionDate>
        <links />
        <text>Introduced in House</text>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <actionCode>Intro-H</actionCode>
        <committee />
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2019-03-18</actionDate>
        <links />
        <text>Introduced in House</text>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <actionCode>1000</actionCode>
        <committee />
        <type>IntroReferral</type>
      </item>
      <actionByCounts>
        <houseOfRepresentatives>3</houseOfRepresentatives>
      </actionByCounts>
      <actionTypeCounts>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
        <billReferrals>1</billReferrals>
      </actionTypeCounts>
    </actions>
    <latestAction>
      <actionDate>2019-03-18</actionDate>
      <text>Referred to the House Committee on Energy and Commerce.</text>
      <links />
    </latestAction>
    <title>Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.</title>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

